<h4>Introduction</h4>Serum neurofilament light chain (NfL) and glial fibrillary acidic protein (GFAP) may synergistically enhance early risk stratification of multiple sclerosis (MS) diagnosis after clinically isolated syndromes (CIS). The gene discussed is GFAP; the disease is in situ carcinoma.